February 15, 2016

DrugDev to Unveil Site Activation Technology, Showcase the Golden Number, Speak about Transforming Clinical Operations, and Host Welcome Reception at the SCOPE Summit

DrugDev subject matter experts will be active participants in CHI’s conference focused exclusively on helping biopharmaceutical executives optimize global clinical operations

DrugDev is a Premier Sponsor of CHI’s SCOPE Summit for Clinical Ops Executives at the Hyatt Regency Miami (February 23-25, 2016), and its subject matter experts will take an active role in the key industry conference. DrugDev welcomes attendees to join the conversation at exhibit booth #300 as the company:

  • Unveils exciting new site activation technology
  • Showcases the DrugDev Golden Number as featured in the recent launch of the TransCelerate Investigator Registry
  • Hosts a pre-conference welcome reception and happy hour (RSVP here)
  • Chairs several sessions aimed at advancing the use of modern technology to improve clinical trial operations

DrugDev President and CEO Ibraheem (Ibs) Mahmood said, “Every year the SCOPE Summit brings together some of the most innovative minds in clinical trials. As always, we look forward to working with our colleagues at leading sponsors and CROs to take bold steps forward that impact the entire industry – for example, our new site activation technology, payments technology, and the DrugDev Golden Number. SCOPE is a unique learning opportunity which helps us understand the challenges and priorities that will drive innovation in 2016 directly from the decision makers who run clinical trials worldwide.”

SCOPE sessions featuring DrugDev experts include:

Tuesday, February 23

  • 2:55pm – Standardizing Clinical Trial Operations Data Across the Industry; A Look Inside the TransCelerate Investigator Registry Data Model – Elisa Cascade, President, DrugDev Data Solutions
  • 4:00pm – Why Technology Fails (Roundtable Discussion) – DrugDev Executive Chairman Hugo Stephenson, MD

Wednesday, February 24

  • 12:10pm – Speed Site Activation Using Collaborative Technology for Contracting and Essential Site Docs (Lunch Session) – Ibs Mahmood and Melissa (Liss) Easy, DrugDev Founder and President of SiteStart
  • 5:20pm – Panel Discussion, Faces in the Crowd: Why We Do What We Do – Brett Kleger, Chief Commercial Officer, DrugDev

Thursday, February 25

  • 7:45am – How One (Golden) Number Can Transform Clinical Trials (Breakfast Session) – Elisa Cascade
  • 12:20pm – Can We Shift Investigators from “1 and Done” to Repeat Performers? – Claire Sears, PhD, DrugDev Director of Investigator Engagement

About DrugDev
DrugDev’s unified platform enables sponsors, CROs and sites to do more trials through industry-wide collaboration, standardization and a beautiful technology experience. Featuring solutions for global site payments, site identification and activation, workflow optimization, learning management, and site and patient engagement, DrugDev helps companies transform the quality and efficiency of clinical trials from startup through closeout. The company also powers the revolutionary TransCelerate Investigator Registry and Investigator Databank collaborations with the universal identifier known as the DrugDev Golden Number. Learn why 9 of the top 10 sponsors, and 4 of the top 5 CROs, trust DrugDev technology at